Hot Topics »
 

14 Comments

  • Zeno Davatz One year ago

    This is a great interview. Thanks for being frank about people who like “to google” about their destiny.

    • Howard Lindzon One year ago

      He definately does not talk like that on the golf course.

      • Broker A One year ago

        I understand a strict birdseed diet will eliminate ones chances of getting cancer.

        Ask the Doc, is this true– and if so, can I go with ranch flavored bird seeds too?

        • A One year ago

          feedback on this subject. Enjoy your sight, found thru Alpha Trends.

          Rgds, A

          http://www.depmed.ualberta.ca/dca/

          • Kristine One year ago

            Great report, Wallstrip. You can be fantastically funny and dead serious. That’s what we love about you!

            • Tuyen One year ago

              Another great show. On another note, what’s up with the new streaming service? Seems to run slower than Revver.

              • micro_idot One year ago

                the educated patient … makes the docs job easier - perhaps defunct … yes - i just said it - defunct. targeted drugs - oh, a concept … duh !

                Note: the barium picture … guess no lead in throat in clip art.

                Stand behind stats … quit smoking … no where is my darn bong ?

                Hard work in genomics - hard work will pay off ?
                of course it is already bearing fruit - just not at the break neck speed wallstreet likes.

                Lyns:

                The interview was fare. But not really very good. It was almost like snippets of topic facts.

                Look - the major players in the cancer antibody market … you should have mentioned them … Genentech, Amgen, ImClone.

                You should have also talked about emerging trends and or sub markets driven by the biopharm growth story … like contract manufacturers or materials and goods supplied into biopharm - it is a friggin immense area.

                You did not not even a squeak of consideration of where biotech and cancer will go - except the genomics quip - a blurb.

                Perhaps the expectation is for Wallstrip to deliver more here … but this is a stock market death and life up/down danger area - with great potential … DNA, ALXN … etc … and great disappointment … IMCL … etc.

                Style: C
                Content: C
                Lack of Future Thinking: C
                Lack of Companies: C
                Doctor’s Teeth: C

                Overall: C

                • Fresh Bread One year ago

                  Barium liquid is used for x-rays: http://www.umm.edu/radiology/barium.htm

                  • maximo zeledon One year ago

                    Great story! You guys rock. Keep up the good work.

                    • howard lindzon One year ago

                      Thanks maximo

                      also - Mr. Wilson dug up this story on the 5 Biotech ETF’s
                      http://etf.seekingalpha.com/article/21234

                      • Alex One year ago

                        hi there,
                        nice interview. Thanks for NOT talking about stocks afterwards.
                        Regards
                        Alex
                        (try my game!)

                        • Alex One year ago

                          oops wrong link. sorry.
                          http://ghot.chinamauer.de

                          • Rob D One year ago

                            Great show, would suggest taking a look at Celiac disease. For a long time it was thought to be 1 in 5000, recent studies show 1 in 133 have it. Furthermore about 95% of the people who have it think they have something else.

                            Trends:
                            Awareness is up, someone the view has it, and talks about it.
                            Startup Biotechs working on drug - ex. Alba in Baltimore
                            Anheuser-Busch just released a gluten-free beer

                            • Mary Ann Marks One year ago

                              Thank you, Jeffrey Marks, and all the rest of you at Wallstrip for this segment. Jeff knows what it is like to be the son of a 48 year cancer survivor. Early detection, targeted treatment, healthy lifestyle, and the new era of nutriceuticals are bringing us into an era of prevention and survivorship. Keep up the good work. Your message will save many lives.

                              Leave a Reply